Lancet系列に投稿する際のガイドライン

Lancet系列に投稿する際のガイドラインです
その中から文書の作成フォーマットについて抜粋、備忘録的に記しています
翻訳にかけたい方にもお役に立つかもしれません

#出典　https://www.thelancet.com/which-journal

持ち物リスト

First submissions to The Lancet Infectious Diseases should
include:
1 Covering letter
2 Manuscript including tables and panels
3 Figures
4 Author statement form (see next section)
5 Declaration of interests and source of funding statements
(see next section)
6 In-press papers—one copy of each with acceptance letters
7 Protocols and CONSORT details for randomised controlled
trials (see Articles)
8 We encourage disclosure of correspondence from other
journals and reviewers, if previously submitted, and we
might contact relevant editors of such journals
9 Research in context panel, for all primary research Articles

細かいガイドライン

All Articles should, as relevant:
• Be up to 3500 words (4500 for randomised controlled trials) with
30 references (the word count is for the manuscript text only)
• Include an abstract (semistructured summary), with five
paragraphs (Background, Methods, Findings, Interpretation,
and Funding), not exceeding 250 words. Our electronic
submission system will ask you to copy and paste this section at
the “Submit Abstract” stage
• For randomised trials, the abstract should adhere to CONSORT
extensions: abstracts (see Lancet 2008; 371: 281–83)
• When reporting Kaplan-Meier survival data, at each timepoint,
authors must include numbers at risk, and are encouraged to
include the number of censored patients.
• For intervention studies, the abstract should include the primary
outcome expressed as the difference between groups with a
confidence interval on that difference (absolute differences are
more useful than relative ones). Secondary outcomes can be
included as long as they are clearly marked as secondary and all
such outcomes are reported
• Use the recommended international non-proprietary name
(rINN) for drug names. Ensure that the dose, route, and
frequency of administration of any drug you mention are correct
• Use gene names approved by the Human Gene Organisation.
Novel gene sequences should be deposited in a public database
(GenBank, EMBL, or DDBJ), and the accession number provided.
Authors of microarray papers should include in their submission
Information for Authors
WHO’s International Clinical
Trial Registry Platform
http://www.who.int/ictrp/
network/trds/en/index.html
Clinical trials
http://clinicaltrials.gov
ICMJE recommendations
http://icmje.org/
recommendations/browse/
publishing-and-editorial-issues/
clinical-trial-registration.html
CONSORT 2010 guidelines
http://www.consortstatement.org/consort-2010
CONSORT extended guidelines
http://www.consort-statement.
org/extensions/extensions/
STARD guideline
http://www.equator-network.
org/reporting-guidelines/stard/
STROBE statement
http://www.strobe-statement.
org/
STREGA guidelines
http://www.equator-network.
org/reporting-guidelines/
strobe-strega/
PRISMA guidelines
http://www.prisma-statement.
org/
Formatting guidelines for
meta-analyses
https://www.thelancet.
com/for-authors/
forms?section=meta-analysis
GATHER statement
http://www.thelancet.com/
journals/lancet/article/
PIIS0140-6736(16)30388-9/
fulltext
CONSORT-AI Extension
guidelines
https://doi.org/10.1016/
S2589-7500(20)30218-1
SPRIT-AI Extension guidelines
https://doi.org/10.1016/
S2589-7500(20)30219-3
To find reporting guidelines, see
http://www.equator-network.
org
Patient Consent form
http://www.thelancet.com/
pb/assets/raw/Lancet/authors/
lancet-consent-form.pdf
Human Gene Organisation
http://www.genenames.org/
Formatting guidelines for
randomised trials
https://www.thelancet.com/
for-authors/forms?section=rct
Information for Authors
www.thelancet.com October 2022
the information recommended by the MIAME guidelines.
Authors should also submit their experimental details to one of
the publicly available databases: ArrayExpress or GEO
• Include any necessary additional data as part of your
EM submission
• All accepted Articles should include a link to the full study
protocol published on the authors’ institutional website
(see Lancet 2009; 373: 992 and Lancet 2010; 375: 348)
• We encourage researchers to enrol women and ethnic groups
into clinical trials of all phases, and to plan to analyse data by sex
and by race
• For all study types, we encourage correct use of the terms sex
(when reporting biological factors) and gender (when reporting
identity, psychosocial, or cultural factors). Where possible, report
the sex and/or gender of study participants, and describe the
methods used to determine sex and gender. Separate reporting
of data by demographic variables, such as age and sex, facilitates
pooling of data for subgroups across studies and should be
routine, unless inappropriate. Discuss the influence or
association of variables, such as sex and/or gender, on your
findings, where appropriate, and the limitations of the data.

Formatting guidelines
Language
• Manuscripts should be submitted in English. Authors writing in
Chinese, Portuguese, or Spanish may wish to use the Webshop
(http://webshop.elsevier.com/languageservices) to provide an
English translation of their manuscript for submission

Title page
• A brief title, author name(s), preferred degree (one only),
affiliation(s), and full address(es) of the authors must be included.
The name and address of the corresponding author should be
separately and clearly indicated with email and telephone details

Formatting of text
• Type a single space at the end of each sentence
• Do not use bold face for emphasis within text
• We use a comma before the final “and” or “or” in a list of items
• Type decimal points midline (ie, 23·4, not 23.4). To create a
midline decimal on a PC: hold down ALT key and type 0183 on
the number pad, or on a Mac: ALT shift 9
• Numbers one to ten are written out in words unless they are
used as a unit of measurement, except in figures and tables
• Use single hard-returns to separate paragraphs. Do not use tabs
or indents to start a paragraph
• Do not use the automated features of your software, such as
hyphenation, endnotes, headers, or footers (especially for
references). You can use page numbering
• Guidelines on formatting tables are available in the artwork
guidelines

References
• Cite references in the text sequentially in the
Vancouver numbering style, as a superscripted number after any
punctuation mark. For example:
“…as reported by Saito and colleagues.15”
• Two references are cited separated by a comma, with no space.
Three or more consecutive references are given as a range with an
en rule. To create an en rule on a PC: hold down CTRL key and minus
sign on the number pad, or on a Mac: ALT hyphen
• References in tables, figures, and panels should be in numerical
order according to where the item is cited in the text
• Here is an example for a journal reference (note the use of tab,
bold, italic, and the en rule or “long” hyphen):
“…15[tab]Saito N, Ebara S, Ohotsuka K, Kumeta
J, Takaoka K. Natural history of scoliosis in spastic
cerebral palsy. Lancet 1998; 351: 1687–[en rule]92.”
• Give any subpart to the title of the article. Journal names are
abbreviated in their standard form as in Index Medicus
• If there are six authors or fewer, give all six in the form:
surname space initials comma
• If there are seven or more give the first three in the same way,
followed by et al
• For a book, give any editors and the publisher, the city of
publication, and year of publication
• For a chapter or section of a book, also give the authors and title
of the section, and the page numbers
• For online material, please cite the URL, together with the date
you accessed the website
• Online journal articles can be cited using the DOI number
• References that are in press can be cited in the reference list with
“(in press)” added after the journal name
• For personal communications and unpublished work, please cite
in-text rather than in the reference list in the format
“(unpublished)” or “(Smith R, unpublished)” if it is your own
observation, or “(Jones E, institution, personal communication)”
if it is someone else’s observation
• Do not put references in the Summary or Research in context
and Search strategy and selection criteria panels
• If preprints are central to your work or cover crucial developments
in the topic(s) covered in your paper, but are not yet formally
published, these may be referenced. Preprints should be clearly
marked as such, for example by including [preprint] before the
reference, and specifically referred to as a preprint in the main
text. Where a preprint has subsequently become available as a
peer-reviewed article, the formal publication should be used as
the reference.

Figures
Our in-house illustrators redraw most figures into Lancet style. The
quality of the files we receive from authors has a direct effect on the
accuracy and time taken to prepare figures that are suitable for
publication.
We have different criteria for photographic and illustrative files, the
following notes are a summary of our ideal requirements, but a
detailed description is in the artwork guidelines
• For images (photographs or photographic images) that are used
as part of illustration or image composite figures we require a
file that is no less than 300 dpi when set at its final printed size.
Ideal file formats are TIF or JPG
• For trial profiles, study profiles, and CONSORT diagrams, please
supply as an editable flow diagram in Word (.doc) or PowerPoint
(.ppt) file
• For illustrations (all non-photographic line-work and general
drawing) we require editable vector files that contain selectable
geometry and fonts (editable text). The editability of files depends
on the package they were created in, but as a rule we would prefer
to receive any of the following: Adobe Illustrator (.ai) file; Adobe
Illustrator or generic .eps files exported from a graphics program;
vector-based PDF, PowerPoint, or Word file; or SVG file. If authors
are unable to supply files in any these formats, our in-house
illustrators can offer guidance on whether it is more economical to
export or convert the file into another format, or to redraw from
scratch. When files are exported to eps files, we would prefer text
to be exported “as text” rather than “as objects”, which is especially
crucial for files such as forest plots in which there is a lot of text
• If your figures are annotated, please supply two copies of each of
these figures as separate files (one annotated copy and one nonannotated and editable copy). Our in-house illustrators will
annotate according to journal style using the annotated figures
as a guide. For multi-part figures, please supply the individual
parts as well as a combined version to be used as a guide for our
illustrators to recreate the files
• Images that have been published previously should be
accompanied by a statement indicating permission to reproduce
the image. If required, further assistance can be obtained from
the editorial team. If you have used previously published images,
you must obtain permission from the copyright holder of the
paper, which might be the authors or the publisher. If all the
figures are your own and have not been published before, then
this requirement does not apply

Guidelines for supplementary material
All material should be submitted as one PDF (with a table of contents
and numbered pages) with the paper and will be peer reviewed.
Material will be published at the discretion of The Lancet journals’
editors. For clinical trials, we encourage authors to include a copy of
the study protocol. All material should be provided in English.

Text
• Main heading for the web extra material should be in 12 point
Times New Roman font BOLD
• Text should be in 10 point Times New Roman font, single spaced
• Headings should be in 10 point BOLD

Tables
• Main table heading should be in 10 point Times New Roman
font BOLD
• Legends should be in 10 point, single spaced
• Tables should be in 8 point Times New Roman font, single
spaced
• Headings within tables should be in 8 point BOLD

Data
• Numbers in text and tables should always be provided if
% is shown
• Means should be accompanied by SDs, and medians by IQR
• p values should be given to two significant figures, unless
p<0·0001

Drug names
• Recommended international non-proprietary name (rINN) is
required
• We encourage use of neuroscience-based nomenclature for
psychotropic drugs

References
• Vancouver style—eg,
—Smith A, Jones B, Clements S. Clinical
transplantation of tissue-engineered airway.
Lancet 2008; 372: 1201–09.
—Hourigan P. Ankle injuries. In: Chan D, ed. Sports
medicine. London: Elsevier, 2008: 230–47.
• Numbered in order of mention in Webappendix and numbered
separately from references in the full paper

Figures
• All images must have a minimum resolution of 300 dpi,
width 107 mm
• Main figure heading should be in 10 point Times New Roman
font BOLD
• Legends should be in 10 point, single spaced
Audio/video material
• The paper to which the audio or video clip relates should be
mentioned in the recording
• Audio clip and video files should be accompanied with brief
text explaining the content of the audio, names of interviewers/
interviewees, date of recording, and place of recording if
relevant
• Written consent from all parties must be supplied at submission

Audio
• Audio material submitted as an mp3 file, no larger than 50 Mb
• Your paper may be selected for a podcast. If so, the Web Editor
will contact you to arrange a pre-recorded interview to discuss
your paper. For more information, see Audio

Video
• Video material should be submitted in .mp4 format with
aspect ratio of 16:9, and be no larger than 50 Mb
• We welcome your videos and invite you to submit any
video material (reports, interviews, scans, imaging) for
consideration in the online journal. Please ensure that
all those featured in the video have given permission for
publication (see also the previous section on Patient and
other consents)
• All video files can be submitted alongside your article in EM

ガイドラインは以上です
ここからはTips的に

Lancet系列で必須の忘れがちなものは

The Panel of research context

です
必要とされているのは “Evidence before this study”,”Added value of this study”,”Implications of all the available evidence”の3つです
これまでの報告で分かっていること、この研究の内容、この研究と合わせて言える事
このコーナーを作る必要があります

Data sharing

こちらも国内誌では書き慣れない内容
データの分析不正を防ぐために、検証を可能にするデータ共有に関する声明です
可、不可はいずれでも構わないとされていますが、可であるに越したことはないでしょう
「未定」は受け入れられないとされています

記載例としては以下のような形
De-identified data of this study are areavailable from the corresponding author on reasonable request.

以下は投稿規定の抜粋です

Data sharing
From September 21, 2020, all submitted research Articles must
contain a data sharing statement, to be included at the end of the
manuscript. Data sharing statements must include:

Whether data collected for the study, including individual
participant data and a data dictionary defining each field in
the set, will be made available to others (“undecided” is not an
acceptable answer);

What data will be made available (deidentified participant
data, participant data with identifiers, data dictionary, or other
specified data set);

Whether additional, related documents will be available (eg,
study protocol, statistical analysis plan, informed consent form);

When these data will be available (beginning and end date, or
“with publication”, as applicable);

Where the data will be made available (including complete URLs
or email addresses if relevant);

By what access criteria data will be shared (including with whom,
for what types of analyses, by what mechanism – eg, with or
without investigator support, after approval of a proposal, with
a signed data access agreement – or any additional restrictions).
See table for examples. Clinical trials that begin enrolling participants
on or after Jan 1, 2019, must include a data sharing plan in the trial’s
registration. If the data sharing plan changes after registration, this
should be reflected in the statement submitted and published, and
updated in the registry record. Mendeley Data is a secure online
repository for research data, permitting archiving of any file type and
assigning a permanent and unique digital object identifier (DOI) so
that the files can be easily referenced. If authors wish to share their
supporting data, and have not already made alternative arrangements,
a Mendeley DOI can be referred to in the data sharing statement.

Lancet系列特有の注意点として
ピリオドが中点です
どういう事かというと・・・

Formatting of textの所にある
• Type a single space at the end of each sentence
• Do not use bold face for emphasis within text
• We use a comma before the final “and” or “or” in a list of items
• Type decimal points midline (ie, 23·4, not 23.4). To create a
midline decimal on a PC: hold down ALT key and type 0183 on
the number pad, or on a Mac: ALT shift 9

この部分
要するに小数点のを真ん中に持ってきてコンマと区別できるようにしろ (.→·)という事
書いてあるようにALT+0183で特殊文字として入力できます

ただし左Alt キー＋数字キーの特殊文字入力には注意が必要です
数字はキーボード上段の数字キーからの入力では正しく変換されず、テンキーで、テンキーがない場合はNumLockキーをロックし、通常キーボードの数字を使う必要があります

このdesimal point midline化めんどくさーーーー！ってなる方も多いですが
簡単に半自動で出来ます！
ALT 0183を多用する必要はありません
Wordの置換機能＋ワイルドカード機能を使い、写真のように次々に変換していくことが出来ます

ワイルドカードはオプションから選択

検索する文字列：([0-9]).([0-9])
置換後の文字列：\1·\2

と入力して置換していくだけです